NDC 0409-2347
Dobutamine in Dextrose
Dobutamine In Dextrose
Dobutamine in Dextrose is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Dobutamine Hydrochloride.
| Product ID | 0409-2347_03a39c90-e78b-4864-8d4c-b11ea1af9fc5 |
| NDC | 0409-2347 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dobutamine in Dextrose |
| Generic Name | Dobutamine In Dextrose |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2006-01-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020201 |
| Labeler Name | Hospira, Inc. |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 200 mg/100mL |
| Pharm Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |